WallStreetZenWallStreetZen

NASDAQ: INBX
Inhibrx Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Inhibrx Biosciences earnings were -$130.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest INBX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$33.4M, up 1.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, INBX reported annual earnings of -$140.1M, with -108.3% growth. The next INBX earnings date is Aug 12, 2026.

INBX earnings history

Current Revenue
$1.3M
Current Earnings
-$130.2M
Current Profit Margin
-10,014.2%

INBX Return on Equity

Current Company
-563.9%
Current Industry
-141.9%
Current Market
13.5%
INBX's Return on Equity (-563.9%)... subscribe to Premium to read more.
High Return on Equity Performance

INBX Return on Assets

Current Company
-72.3%
Current Industry
-13.7%
INBX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INBX announces earnings.

INBX Return on Capital Employed

Current Company
-74.41%
Current Industry
-9.6%

INBX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INBX-$112.97M-$130.19MN/A-$8.39
ARDX-$31.67M-$58.06MN/A-$0.24
AKTSN/AN/AN/AN/A
VOR-$876.54M-$883.08MN/A-$70.13
SPTXN/AN/AN/AN/A
View Top Biotech Stocks

INBX earnings dates

Next earnings date
Aug 12, 2026

Inhibrx Biosciences Earnings Reports & History FAQ

What were Inhibrx Biosciences's earnings last quarter?

Inhibrx Biosciences (NASDAQ: INBX) reported Q1 2026 earnings per share (EPS) of -$2.15, up 23.21% year over year. Total INBX earnings for the quarter were -$33.44 million. In the same quarter last year, Inhibrx Biosciences's earnings per share (EPS) was -$2.80.

If you're new to stock investing, here's how to buy Inhibrx Biosciences stock.

When does Inhibrx Biosciences report earnings?

The next INBX earnings date is Aug 12, 2026. Add INBX to your watchlist to be reminded of Inhibrx Biosciences's next earnings date.

Is Inhibrx Biosciences profitable or losing money?

As of the last Inhibrx Biosciences earnings report, Inhibrx Biosciences is currently losing money. Inhibrx Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$130.19 million, a 107.56% decrease year over year.

What was INBX's earnings growth in the past year?

As of Inhibrx Biosciences's earnings date in Q3 2026, Inhibrx Biosciences's earnings has grown year over year. INBX earnings in the past year totalled -$130.19 million.

What are Inhibrx Biosciences's earnings expectations?

The current EPS estimate for Inhibrx Biosciences's earnings report in Aug 12, 2026 is -$2.50.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.